| Semra Sahinci, MD | |
|
166 Defense Hwy Ste 303, Annapolis, MD 21401-8926 | |
| (240) 914-8721 | |
| (240) 513-7104 |
| Full Name | Semra Sahinci |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 28 Years |
| Location | 166 Defense Hwy Ste 303, Annapolis, Maryland |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1720067713 | NPI | - | NPPES |
| 126387 | Other | MD | JHHC |
| 405199800 | Medicaid | MD | |
| 64180604 | Other | MD | BCBS |
| 7007769 | Other | MD | AETNA |
| 0008 | Other | DC | BCBS |
| 1698049 | Other | MD | AETNA HMO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | D0061321 (Maryland) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Homecall | Easton, MD | Home health agency |
| Anne Arundel Medical Center | Annapolis, MD | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Luminis Health Medical Group, Llc | 2860447315 | 431 |
News Archive
According to results from a Phase I/IIa trial at The University of Texas MD Anderson Cancer Center, treatment with cord blood-derived chimeric antigen receptor natural killer (NK)-cell therapy targeting CD19 resulted in clinical responses in a majority of patients with relapsed or refractory non-Hodgkin's lymphoma and chronic lymphocytic leukemia, with no major toxicities observed.
Genevac, a world leader in solvent removal technologies, has released a new 24-page guide ‘Introduction to Evaporation'.
Fast, efficient and readily available medical attention is key to survival in a health emergency. When a person is stricken with injury or illness, getting a quick and accurate diagnosis through medical imaging technology can be crucial for ensuring proper treatment. For people who live in major cities and towns where fully-equipped hospitals are only a quick ambulance ride away, that's not usually a problem. But for those without medical facilities within easy reach, it can mean the difference between life and death.
Women who are considering becoming pregnant may significantly reduce their risk of developing a common life-threatening complication called preeclampsia by taking a multivitamin supplement regularly three months before conception and during the first trimester of pregnancy.
National Science Foundation funding to develop and commercialize artificially-manufactured cells and cell platforms for educational, research and industry application has been awarded to a team of scientists led by Dr. Mark DeCoster, the James E. Wyche III Professor in Biomedical Engineering at Louisiana Tech University.
› Verified 3 days ago
| Entity Name | Luminis Health Medical Group, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073580205 PECOS PAC ID: 2860447315 Enrollment ID: O20050317000146 |
News Archive
According to results from a Phase I/IIa trial at The University of Texas MD Anderson Cancer Center, treatment with cord blood-derived chimeric antigen receptor natural killer (NK)-cell therapy targeting CD19 resulted in clinical responses in a majority of patients with relapsed or refractory non-Hodgkin's lymphoma and chronic lymphocytic leukemia, with no major toxicities observed.
Genevac, a world leader in solvent removal technologies, has released a new 24-page guide ‘Introduction to Evaporation'.
Fast, efficient and readily available medical attention is key to survival in a health emergency. When a person is stricken with injury or illness, getting a quick and accurate diagnosis through medical imaging technology can be crucial for ensuring proper treatment. For people who live in major cities and towns where fully-equipped hospitals are only a quick ambulance ride away, that's not usually a problem. But for those without medical facilities within easy reach, it can mean the difference between life and death.
Women who are considering becoming pregnant may significantly reduce their risk of developing a common life-threatening complication called preeclampsia by taking a multivitamin supplement regularly three months before conception and during the first trimester of pregnancy.
National Science Foundation funding to develop and commercialize artificially-manufactured cells and cell platforms for educational, research and industry application has been awarded to a team of scientists led by Dr. Mark DeCoster, the James E. Wyche III Professor in Biomedical Engineering at Louisiana Tech University.
› Verified 3 days ago
| Entity Name | Vip Physician Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134909955 PECOS PAC ID: 5597111542 Enrollment ID: O20231026002657 |
News Archive
According to results from a Phase I/IIa trial at The University of Texas MD Anderson Cancer Center, treatment with cord blood-derived chimeric antigen receptor natural killer (NK)-cell therapy targeting CD19 resulted in clinical responses in a majority of patients with relapsed or refractory non-Hodgkin's lymphoma and chronic lymphocytic leukemia, with no major toxicities observed.
Genevac, a world leader in solvent removal technologies, has released a new 24-page guide ‘Introduction to Evaporation'.
Fast, efficient and readily available medical attention is key to survival in a health emergency. When a person is stricken with injury or illness, getting a quick and accurate diagnosis through medical imaging technology can be crucial for ensuring proper treatment. For people who live in major cities and towns where fully-equipped hospitals are only a quick ambulance ride away, that's not usually a problem. But for those without medical facilities within easy reach, it can mean the difference between life and death.
Women who are considering becoming pregnant may significantly reduce their risk of developing a common life-threatening complication called preeclampsia by taking a multivitamin supplement regularly three months before conception and during the first trimester of pregnancy.
National Science Foundation funding to develop and commercialize artificially-manufactured cells and cell platforms for educational, research and industry application has been awarded to a team of scientists led by Dr. Mark DeCoster, the James E. Wyche III Professor in Biomedical Engineering at Louisiana Tech University.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Semra Sahinci, MD 166 Defense Hwy Ste 303, Annapolis, MD 21401-8926 Ph: (240) 914-8721 | Semra Sahinci, MD 166 Defense Hwy Ste 303, Annapolis, MD 21401-8926 Ph: (240) 914-8721 |
News Archive
According to results from a Phase I/IIa trial at The University of Texas MD Anderson Cancer Center, treatment with cord blood-derived chimeric antigen receptor natural killer (NK)-cell therapy targeting CD19 resulted in clinical responses in a majority of patients with relapsed or refractory non-Hodgkin's lymphoma and chronic lymphocytic leukemia, with no major toxicities observed.
Genevac, a world leader in solvent removal technologies, has released a new 24-page guide ‘Introduction to Evaporation'.
Fast, efficient and readily available medical attention is key to survival in a health emergency. When a person is stricken with injury or illness, getting a quick and accurate diagnosis through medical imaging technology can be crucial for ensuring proper treatment. For people who live in major cities and towns where fully-equipped hospitals are only a quick ambulance ride away, that's not usually a problem. But for those without medical facilities within easy reach, it can mean the difference between life and death.
Women who are considering becoming pregnant may significantly reduce their risk of developing a common life-threatening complication called preeclampsia by taking a multivitamin supplement regularly three months before conception and during the first trimester of pregnancy.
National Science Foundation funding to develop and commercialize artificially-manufactured cells and cell platforms for educational, research and industry application has been awarded to a team of scientists led by Dr. Mark DeCoster, the James E. Wyche III Professor in Biomedical Engineering at Louisiana Tech University.
› Verified 3 days ago
Amy Bernardino, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 888 Bestgate Rd, Annapolis, MD 21401 Phone: 410-571-7300 | |
Dr. Lyn Nguyen Dea, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 129 Lubrano Dr, Suite 100, Annapolis, MD 21401 Phone: 410-266-5852 Fax: 410-266-5095 | |
Dr. Charles Adamo, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 2629 Riva Rd, Siote 112, Annapolis, MD 21401 Phone: 410-266-1000 Fax: 410-573-4028 | |
Dr. Eman Hussain Al-samrrai, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1419 Forest Dr, Annapolis, MD 21403 Phone: 410-990-0050 | |
Dr. Andrew P Mcglone, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2002 Medical Pkwy, Suite 670, Annapolis, MD 21401 Phone: 443-481-1150 Fax: 410-225-0065 | |
Dr. Anne N. Bowen, D.O. Family Medicine Medicare: Medicare Enrolled Practice Location: 695 Kinkaid Rd, Annapolis, MD 21402 Phone: 410-293-2273 Fax: 410-293-1163 | |
Dr. Patricia Ann Bowyer, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2051 West St, Annapolis, MD 21401 Phone: 443-603-0758 |